Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Apr 24, 2022 9:52am
126 Views
Post# 34627141

RE:RE:RE:RE:RE:RE:$$$ GO VPT shake,shake next news 🚀🚀$$$

RE:RE:RE:RE:RE:RE:$$$ GO VPT shake,shake next news 🚀🚀$$$
jopatclo wrote: momentum is building. The Acc conference shows us the scope and complexity of the healthcare system. Having GE as a partner means our time will come. The numbers are staggering. $4 trillion per year spent on health care. Just the United States. 30 million echocardiograms per year, again just in the United States. 10-20% of those that are sub-optimal cost an average of $2,000. It's only 60 billion out of 4 trillion. 60/4000 = 1.5%. When our time comes, whoever buys us will just have to lift a couch cushion and find a few nickels. we are part of a much larger whole. The people and companies that partner and invest their time with us wouldn't be wasting their time if it didn't make a difference. For those impatient for the sales, the momentum is rising.
GEHC appears to be the undisputed leader in the space in which it operates. Bravo GA was able to make this connection over a year ago.
For longs here we keep our actions for our patience and our confidence in VPT and G.A. for health and for the rise in power for our investments with this wonderful product $$$
jopatclo wrote:
soon this game will be behind then the news will make us rise ... to 0.67 $ $$$ and the negative messages too ...

V:VPT - VENTRIPOINT DIAGNOSTICS LTD - https://www.ventripoint.com 15:33:27 HAE
Sym-X Demande d'offre Durer Chg %Ch Volume vol $ #Tr Ouvert-Salut-Lo Anne Hi-Lo Dernire Tr Nouvelles Retard
VPT -V   29,0 0,355 · 0,37 9.5 0,37 +0,01 2.8 475.6 161 134 0,36   0,37   0,34 0,66 0,22 14:35:53 19 avril 15 min RT 2 ¢
TSX-V-V 29,0 0,355 · 0,37 9.5 0,365 +0,005 1.4 201.3 68 61 0,36   0,37   0,34 0,66 0,22 14:35:48   15 min
NEO ATS-U   0,35 -0,01 -2.8 58,0 20 16 0,355   0,355   0,34   13:03:41   15 min
Alpha-A   0,37 +0,01 2.8 111,0 39 13 0,35   0,37   0,34   14:35:48   15 min
Omga-O   0,365 +0,005 1.4 47,0 16 12 0,355   0,365   0,34   14:13:47   15 min
Pur-P   0,365 +0,005 1.4 2.5 1 5 0,355   0,365   0,34   14:35:48   15 min
Chi-X - X   0,35 -0,01 -2.8 0,5 0 1 0,35   0,35   0,35   13:03:41   15 min
CX2-H   0,37 +0,01 2.8 54,5 18 20 0,355   0,37   0,34   14:35:53   15 min
TriAct - M   0,36     0,8 0 6        05-19 dcembre   15 min

 

Transactions rcentes - Dernires 10 sur 134
Heure ET Ex Prix Changer Le volume Acheteur Vendeur Marqueurs
14:35:53 H 0,37 0,01 3 500 1 Anonyme 7 secondes TD K
14:35:53 H 0,37 0,01 3 500 1 Anonyme 2 RBC K
14:35:53 H 0,37 0,01 4 000 1 Anonyme 80 Banque Nationale K
14:35:53 H 0,37 0,01 1 000 1 Anonyme 1 Anonyme K
14:35:53 H 0,37 0,01 500 1 Anonyme 1 Anonyme K
14:35:48 UN 0,37 0,01 6 000 79 Banque CIBC 79 Banque CIBC K
14:35:48 P 0,365 0,005 500 79 Banque CIBC 1 Anonyme K
14:35:48 V 0,365 0,005 1 000 79 Banque CIBC 80 Banque Nationale K
14:13:47 UN 0,365 0,005 6 500 19 Desjardins 79 Banque CIBC K
14:13:47 H 0,365 0,005 500 19 Desjardins 1 Anonyme K




ONLY 60 billion.
Where do you get this stuff?
Do you just make it up?
No wonder you are the lead promoter.
 
The real aspirational number for the GLOBAL cardiac ultrasound market is 1.2-2+ Billion.
I am keen to see real numbers like you say as of course it would look great, but lets look at the facts
 
ML Research Holds Promising Potentials for Automated Echo Analysis, Interpretation Systems
 
The echocardiography market is projected to cross a revenue of US$ 2.2 Bn by 2030. A plethora of algorithms are being proposed to analyze medical ultrasound data using signal processing and machine learning (ML) techniques. However, there is a need to develop robust systems suitable for efficient use in clinical settings of point-of-care testing. Thus, med-tech companies in the echocardiography market are bolstering their R&D activities to advance in the field of automatic echo analysis.”
https://www.transparencymarketresearch.com/echocardiography-market.html
 
The global cardiovascular ultrasound market size was valued at USD 1.3 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2028. A rise in penetration of preventive medicine and increasing prevalence of Cardiovascular Diseases (CVDs) are expected to propel the market growth. “
https://www.grandviewresearch.com/industry-analysis/cardiovascular-ultrasound-system-market

and yes VPT so far has zero out of that 1.3Billion yet GEHC will buy them out for that???
How say you this???

<< Previous
Bullboard Posts
Next >>